Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Müller Glia-Exclusive CLRN1 Expression Drives Non-Cell-Autonomous Photoreceptor Degeneration in Usher Syndrome Type 3A.

Investigative ophthalmology & visual science·2026
Same author

Application of a Quantitative Vascular Severity Score in Retinopathy of Prematurity in the United States and India: New Insights Into Disease Epidemiology and Pathophysiology.

American journal of ophthalmology·2026
Same author

Physics-driven deep learning photoacoustic tomography.

Fundamental research·2026
Same author

Beyond the Retina-OCT Insights Into Neurodevelopment.

JAMA ophthalmology·2026
Same author

A low-cost, tunable suprachoroidal injection platform with real-time OCT guidance for gene therapy delivery.

Experimental eye research·2026
Same author

Reply.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2026

Related Experiment Video

Updated: Mar 31, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

14.9K

Neuroprotection and Retinal Diseases.

Yannis M Paulus, J Peter Campbell

    Developments in Ophthalmology
    |October 27, 2015
    PubMed
    Summary

    Neuroprotection strategies aim to prevent neuronal death, a leading cause of vision loss in retinal diseases. Advances in therapies like antioxidative and anti-apoptotic treatments offer hope for improved vision and patient outcomes.

    Area of Science:

    • Ophthalmology
    • Neuroscience
    • Cell Biology

    Background:

    • Neuronal death is the primary cause of vision loss in various retinal diseases.
    • Understanding the mechanisms of neuronal survival is crucial for developing effective treatments.

    Purpose of the Study:

    • To explore the advancements in neuroprotection for retinal diseases.
    • To highlight the therapeutic potential of promoting neuronal survival and function.

    Main Methods:

    • Review of current neuroprotective strategies.
    • Focus on antioxidative therapy.
    • Emphasis on neurotrophic support and anti-apoptotic therapy.

    Main Results:

    • Neuroprotection involves modifying neurons and their environment to enhance survival.

    More Related Videos

    A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure
    07:37

    A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure

    Published on: July 14, 2016

    15.9K
    Morphometric Analyses of Retinal Sections
    14:33

    Morphometric Analyses of Retinal Sections

    Published on: February 19, 2012

    10.8K

    Related Experiment Videos

    Last Updated: Mar 31, 2026

    Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
    07:32

    Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

    Published on: June 23, 2014

    14.9K
    A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure
    07:37

    A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure

    Published on: July 14, 2016

    15.9K
    Morphometric Analyses of Retinal Sections
    14:33

    Morphometric Analyses of Retinal Sections

    Published on: February 19, 2012

    10.8K
  • Therapeutic approaches are improving the conditions for neuronal health in detrimental environments.
  • Conclusions:

    • The field of neuroprotection is progressing with novel therapeutic strategies.
    • These advancements hold promise for improving vision and clinical outcomes in patients with retinal diseases.